Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint Inhibitors
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference42 articles.
1. Safety and efficacy of durvalumab (medi4736), an anti-programmed cell death ligand-1 immune checkpoint inhibitor, in patients with advanced urothelial bladder cancer;Massard;J Clin Oncol,2016
2. Urothelial carcinoma of the bladder and the rise of immunotherapy;Chism;J Natl Comprehen Cancer Netw,2017
3. Response rate to chemotherapy after immune checkpoint inhibition in metastatic urothelial cancer;Szabados;Eur Urol,2018
4. Genomic analysis of tumor microenvironment immune types across 14 solid cancer types: immunotherapeutic implications;Chen;Theranostics,2017
5. Tumor mutational load predicts survival after immunotherapy across multiple cancer types;Samstein;Nat Genet,2019
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of combined radiotherapy with immune checkpoint blockade on immunological memory in luminal-like subtype murine bladder cancer model;Cancer Biology & Therapy;2024-06-11
2. Establishment of a prognosis predictive model for liver cancer based on expression of genes involved in the ubiquitin-proteasome pathway;World Journal of Clinical Oncology;2024-03-24
3. A Systematic Immune and Prognostic Analysis of CD48 Interaction with Tumor Microenvironment in Pan-Cancer;International Journal of General Medicine;2023-11
4. Reconstructing disease dynamics for mechanistic insights and clinical benefit;Nature Communications;2023-10-27
5. Comprehensive information-based differential gene regulatory networks analysis (CIdrgn): Application to gastric cancer and chemotherapy-responsive gene network identification;PLOS ONE;2023-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3